Study confirms the beneficial effect of Tri-Low® full spectrum Amla extract upon dyslipidemia

摘要

A newly published study demonstrates the efficacy and safety of Tri-Low® full extract of amla (Phyllanthus emblica), the Indian gooseberry, in alleviating dyslipidemia, a leading contributing risk factor to the development of atherosclerosis. The amla extract has shown significant potential in reducing total cholesterol and triglyceride levels and in stimulating a more favourable balance of lipid ratios. These results confirm Tri-Low's functionality as a superior, clean-label cardiac health supplement. Arjuna Natural, Ltd., will exhibit Tri-Low and its study results at Vitafoods in Geneva, on May 7-9, booth #C30.